NSCLC is the leading cause of cancer-related death in the US. Patients with NSCLC are
mostly treated with platinum-based chemotherapy, often in combination with radiation therapy. …

We conducted a multi-stage, genome-wide association study of bladder cancer with a
primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of …

Breast, ovarian, and prostate cancers are hormone-related and may have a shared genetic
basis, but this has not been investigated systematically by genome-wide association (GWA) …

We conducted a meta-analysis to identify new susceptibility loci for testicular germ cell tumor
(TGCT). In the discovery phase, we analyzed 931 affected individuals and 1,975 controls …

Purpose The phosphoinositide-3-kinase (PI3K), phosphatase and tensin homolog (PTEN), v-akt
murine thymoma viral oncogene homolog (AKT), and mammalian target of rapamycin (…

Liver function tests (LFTs) have been reported as independent predictors of non-liver
disease-related morbidity and mortality in general population and cancer patients. In this study, we …

Renal cell carcinoma (RCC) is the most lethal urologic cancer. Only two common
susceptibility loci for RCC have been confirmed to date. To identify additional RCC common …

Background: In vitro and observational epidemiological studies suggest that vitamin D may
play a role in cancer prevention. However, the relationship between vitamin D and ovarian …

Treatment of non-small cell lung cancer (NSCLC) with radiotherapy or chemoradiotherapy is
often accompanied by the development of esophagitis and pneumonitis. Identifying patients …

Background Genomic regions identified by genome-wide association studies (GWAS) for
bladder cancer risk provide new insights into etiology. Objective To identify new susceptibility …